MAPT and neurodegenerative disease: The planned biosensor may be used as a substitute test for screening AD and neurodegenerative diseases.49 To ensure a rapid, simple, ultra-sensitive, and specific measurement of tau protein in human serum, a novel electrochemical aptamer-antibody sandwich assay was appropriately assembled.